Sign inGet started

Jansen Valerie Malyvanh

Insider CIK 1889716 · OKUR Director · ELEV Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OKUR OnKure Therapeutics, Inc. A Award deriv2026-08-072026-08-1122,350— $022,350SEC↗
OKUR OnKure Therapeutics, Inc. A Award deriv2026-08-072026-08-1122,350— $022,350SEC↗
OKUR OnKure Therapeutics, Inc. A Award deriv2026-06-042026-06-087,650— $07,650SEC↗
OKUR OnKure Therapeutics, Inc. A Award deriv2025-05-282025-05-307,650— $07,650SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2025-02-152025-02-19275,000— $0275,000SEC↗
ELEV Elevation Oncology, Inc. M Exercise2025-02-152025-02-1917,500— $017,500SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2025-02-152025-02-195,189$0.67 $3.5K12,311SEC↗
OKUR OnKure Therapeutics, Inc. A Award deriv2024-10-042024-10-0815,300— $015,300SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2024-02-152025-02-1917,500— $052,500SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2024-02-152024-02-20225,000— $0225,000SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2024-02-152024-02-2070,000— $070,000SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2023-02-152023-02-17130,000— $0130,000SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2023-01-062023-01-10130,000— $0130,000SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2022-02-142022-02-1660,000— $060,000SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2021-10-192021-10-2140,000— $040,000SEC↗